Alexandre Richard, MBA, is a seasoned leader in M&A and Corporate Development at Sanofi, where they have directed significant transactions in Oncology, Immunology & Inflammation, Neuro, and Rare Diseases since 2013. With over 10 years of experience and 20+ successfully completed transactions, they have showcased a strategic approach and entrepreneurial mindset through projects like the acquisitions of Kiadis Pharma, Principia Biopharma, and Bioverativ. Alexandre holds a Master's in Immuno-Oncology with honors from ESCP Europe and has undergone executive education at INSEAD and a masterclass at London Business School. They previously held roles at Procter & Gamble in various analytical and finance capacities.
This person is not in the org chart
This person is not in any teams
This person is not in any offices